Physician profile
Kelly Lang-Sheppard
NPI 1972940708
$4,689.30
in general payments reported to CMS, 2019-2025
28 companies · $1,964 in 2025
The $1,964 reported for 2025 was more than what 96% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $410 · 2023: $470 · 2024: $1,469 · 2025: $1,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,801 · Gift: $59.40 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,800.99 |
| Gift | $59.40 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $731.89 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $356.93 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $355.15 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $323.95 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Madrigal Pharmaceuticals | $320.86 | 2024-2025 | Rezdiffra, Resmetirom |
| Dexcom, INC. | $319.08 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $290.59 | 2024-2025 | |
| Insulet Corporation | $288.82 | 2021-2025 | Omnipod |
| Corcept Therapeutics | $240.92 | 2023-2025 | Korlym |
| Mannkind Corporation | $237.31 | 2023-2025 | Afrezza |
| Medtronic, INC. | $228.94 | 2023-2025 | Minimed 780g |
| Ascensia Diabetes Care US INC. | $168.08 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.64 | 2022-2025 | Jardiance, Synjardy |
| Beta Bionics, INC. | $129.06 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $112.98 | 2025 | Twiist |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.66 | 2023-2025 | Tepezza, Prolia, Evenity |
| Novo Nordisk INC | $66.78 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Cequr Corporation | $49.00 | 2024-2025 | Cequr Simplicity |
| Abbvie INC. | $35.84 | 2025 | |
| Kyowa Kirin, INC. | $28.04 | 2024 | Crysvita |
| Globus Medical, INC. | $27.46 | 2025 | Omnia |
| Astellas Pharma US INC | $24.77 | 2025 | Veozah |
| Almatica Pharma LLC | $22.28 | 2025 | Teriparatide |
| Astrazeneca Pharmaceuticals Lp | $21.74 | 2021 | |
| Acella Pharmaceuticals, LLC | $19.24 | 2025 | NP Thyroid 60 |
| Bayer Healthcare Pharmaceuticals INC. | $18.92 | 2025 | |
| Alexion Pharmaceuticals, INC. | $15.99 | 2024 | Strensiq |
| Ibsa Pharma INC. | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Lang-Sheppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.